- Home
- RAYA vs BIAF Comparison
RAYA vs BIAF Comparison
Compare RAYA & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- BIAF
- Stock Information
- Founded
- RAYA 2019
- BIAF 2014
- Country
- RAYA China
- BIAF United States
- Employees
- RAYA N/A
- BIAF 57
- Industry
- RAYA Metal Fabrications
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RAYA Consumer Discretionary
- BIAF Health Care
- Exchange
- RAYA Nasdaq
- BIAF Nasdaq
- Market Cap
- RAYA 6.1M
- BIAF 7.1M
- IPO Year
- RAYA 2022
- BIAF 2022
- Fundamental
- Price
- RAYA $0.05
- BIAF $0.25
- Analyst Decision
- RAYA
- BIAF Hold
- Analyst Count
- RAYA 0
- BIAF 1
- Target Price
- RAYA N/A
- BIAF N/A
- AVG Volume (30 Days)
- RAYA 97.6M
- BIAF 531.9K
- Earning Date
- RAYA 01-01-0001
- BIAF 08-14-2025
- Dividend Yield
- RAYA N/A
- BIAF N/A
- EPS Growth
- RAYA N/A
- BIAF N/A
- EPS
- RAYA N/A
- BIAF N/A
- Revenue
- RAYA $30,300,360.00
- BIAF $7,681,059.00
- Revenue This Year
- RAYA $20.95
- BIAF N/A
- Revenue Next Year
- RAYA N/A
- BIAF $20.00
- P/E Ratio
- RAYA N/A
- BIAF N/A
- Revenue Growth
- RAYA 49.10
- BIAF 4.99
- 52 Week Low
- RAYA $0.05
- BIAF $0.16
- 52 Week High
- RAYA $3.35
- BIAF $2.26
- Technical
- Relative Strength Index (RSI)
- RAYA 26.51
- BIAF 41.58
- Support Level
- RAYA $0.05
- BIAF $0.24
- Resistance Level
- RAYA $0.06
- BIAF $0.28
- Average True Range (ATR)
- RAYA 0.01
- BIAF 0.02
- MACD
- RAYA 0.07
- BIAF -0.00
- Stochastic Oscillator
- RAYA 4.44
- BIAF 29.50
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.